PWAM
OPRX icon

Park West Asset Management’s OptimizeRx OPRX Stock Holding History

Park West Asset Management’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-681,330
Closed -$6.17M – 78
2020
Q1 		$6.17M Sell
681,330
-133,338
-16% -$1.26M 0.42% 50
2019
Q4 		$8.37M Sell
814,668
-264,468
-25% -$3M 0.35% 60
2019
Q3 		$15.6M Sell
1,079,136
-8,952
-0.8% -$139K 0.76% 39
2019
Q2 		$17.6M Buy
1,088,088
+133,238
+14% +$1.8M 0.73% 41
2019
Q1 		$12.1M Sell
954,850
-12,598
-1% -$164K 0.53% 46
2018
Q4 		$10.6M Buy
967,448
+375,000
+63% +$5.55M 0.52% 52
2018
Q3 		$10.7M Sell
592,448
-84,220
-12% -$1.06M 0.39% 57
2018
Q2 		$7.04M Buy
+676,668
New +$6.95M 0.26% 77

Other funds holding OPRX

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Park West Asset Management's OPRX Position: Q2 2020 in Review

Park West Asset Management sold out of OptimizeRx (OPRX) in Q2 2020, closing a stake of 681,330 shares — an estimated $6.17M sold.

Park West Asset Management first reported a position in OPRX in Q2 2018 and held it in 8 quarters. The position peaked at $17.6M in Q2 2019. 53 funds tracked by Wall St. Rank hold OPRX as of Q2 2020.

  • Park West Asset Management reported no remaining OptimizeRx position as of Q2 2020 after selling out during the quarter.
  • Park West Asset Management sold 681,330 OptimizeRx shares in Q2 2020, an estimated $6.17M.
  • Park West Asset Management first reported a position in OptimizeRx in Q2 2018 and held it in 8 quarters.
  • Park West Asset Management's OptimizeRx position peaked at $17.6M in Q2 2019.
  • 53 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2020.

Based on Park West Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.